首页> 美国卫生研究院文献>The Scientific World Journal >Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case Report
【2h】

Use of Low Molecular Weight Heparin and Aminocaproic Acid in Chronic DIC Associated with Prostate Cancer- A Case Report

机译:低分子量肝素和氨基己酸在与前列腺癌相关的慢性DIC中的应用-病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Disseminated Intravascular Coagulopathy (DIC) is the most common coagulopathy in patients with prostate cancer. Though rare, it could be fatal without treatment. Literature suggests that there is significant activation of fibrinolytic pathway. Pathophysiology of DIC in patients with prostate cancer is not completely understood. We present here a case of chronic DIC in a patient with metastatic androgen independent prostate cancer. His DIC was managed successfully with a combination of aminocaproic acid and low weight molecular heparin. The use of low molecular weight heparin may make management of chronic DIC in prostate cancer more feasible in an out patient setting.
机译:弥散性血管内凝血病(DIC)是前列腺癌患者中最常见的凝血病。尽管很罕见,但是如果不治疗可能会致命。文献表明纤溶途径的显着激活。 DIC在前列腺癌患者中的病理生理尚未完全了解。我们在这里介绍了患有转移性雄激素非依赖性前列腺癌的患者的慢性DIC病例。氨基己酸和低分子量分子肝素的结合成功地管理了他的DIC。低分子量肝素的使用可能使门诊病人在前列腺癌中慢性DIC的管理更加可行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号